Seedsman Blog
Home » FDA Approves First Cannabis Derived Medicine

FDA Approves First Cannabis Derived Medicine

In an historic moment for medicinal cannabis in the United States, the FDA (Food and Drug Administration) has approved the very first drug containing an active ingredient from the cannabis plant.

The medicine in question is Epidiolex, an oral solution containing cannabidiol, or CBD.

Predominantly used for Epileptic disorders, the FDA have approved the medicine in the U.S. for two specific conditions, Dravet Syndrome and Lennox-Gastaut Syndrome. Both of these Epileptic disorders are extremely rare and extremely dangerous.

While there have been a number of synthetic cannabis based medicines approved by the FDA, this is the very first drug that contains a cannabinoid directly from the cannabis plant.

This breakthrough means that Epidiolex can be prescribed by doctors and covered by medical insurance.

However, just a small percentage of the population of the United States will be able to access the medicine. Only 3 in around 115,000 children are born with Dravet or Lennox-Gastaut Syndrome.

And yet this long overdue approval by the FDA will provide them with the medicine they so desperately need.

Cultivation information, and media is given for those of our clients who live in countries where cannabis cultivation is decriminalised or legal, or to those that operate within a licensed model. We encourage all readers to be aware of their local laws and to ensure they do not break them.


Not only do we have one of the most comprehensive libraries of cannabis seeds in the world, we now offer a diverse range of cannabis related goods for you to enjoy including storage products, clothing and books.